Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Caspase 9 Antibody
NCTP00015
Description: Rabbit polyclonal to human Caspase 9
Application: ELISA, WB, IF
Reactivity: Human
Catalog #: NCTP00015
$375.00
1000 Items
Overview
| DESCRIPTION | |
| Species Reactivity | Human. Other species not tested. |
| Isotype | lgG |
| Immunogen | 14 aa peptide from the middle region of human Caspase 9. |
| Accession # | P55211 |
| Alternative Names | Caspase-9; Apoptotic protease Mch-6; Apoptotic protease-activating factor 3; CASP-9; Mch-6; APAF-3; ICE-like apoptotic protease 6; ICE-LAP6 |
| Purification | Peptide affinity column. |
| Formulation | Lyophilized with 1% BSA and 0.02% NaN3. |
| Size | 200µl |
| APPLICATION | |
| ELISA | 1:5,000 - 1:20,000 |
| Western Blot | 1:200 - 1:500 |
| Immunofluorescence | 1:50 - 1:100 |
| - | For research use only. Optimal dilutions/concentrations should be determined by each laboratory for each application. |
| PREPARATION AND STORAGE | |
| Reconstitution | Reconstitute in 200µl of sterile H2O. |
| Storage | Shipped at ambient temperature. Store immediately at -20°C upon receipt. Avoid repeated freeze-thaw cycles. |
| REFERENCES | |
| - | Gregory,S.G., Barlow,K.F., McLay,K.E., et al. The DNA sequence and biological annotation of human chromosome 1. Nature 2006; 441 (7091): 315-321. |